Article Information
History
- January 14, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Joshua A. Rushakoff, MD, MPP1,
- Loren Gragert, PhD2,3,
- Marcelo J Pando, PhD4,
- Darren Stewart, MS5,
- Edmund Huang, MD6,
- Irene Kim, MD6,
- Stanley Jordan, MD6,
- Kelsi Lindblad, PhD5,
- Xiaohai Zhang, PhD6,
- Peter Lalli, PhD7,
- Jignesh K. Patel, MD, PhD1,
- Jon A. Kobashigawa, MD1 and
- Evan P. Kransdorf, MD, PhD1,*
- 1Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
- 2Department of Pathology, Tulane University School of Medicine, New Orleans, Louisiana, USA
- 3National Marrow Donor Program, Minneapolis, Minnesota, USA
- 4Transplant Immunology Laboratory, Scott & White Medical Center, Temple, Texas
- 5Research Department, United Network for Organ Sharing, Richmond, Virginia, USA
- 6Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA
- 7Histocompatibility Laboratory, Carolinas Healthcare System, Charlotte, North Carolina, USA
- ↵*Corresponding Author:
Evan Kransdorf, MD, PhD, 8670 Wilshire Blvd, Suite 200, Beverly Hills, CA 90211, phone 310-248-8300, fax 310-248-8333, email: evan.kransdorf{at}cshs.org
Posted January 14, 2022.
Human Leukocyte Antigen Homozygosity Contributes to Sensitization in Kidney Transplant Candidates
